341 related articles for article (PubMed ID: 37598318)
1. Endocrine-disrupting compounds and metabolomic reprogramming in breast cancer.
Winz C; Zong WX; Suh N
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23506. PubMed ID: 37598318
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.
Rachoń D
Rev Endocr Metab Disord; 2015 Dec; 16(4):359-64. PubMed ID: 26831296
[TBL] [Abstract][Full Text] [Related]
3. Endocrine disrupting chemicals and breast cancer cells.
Darbre PD
Adv Pharmacol; 2021; 92():485-520. PubMed ID: 34452695
[TBL] [Abstract][Full Text] [Related]
4. Endocrine disrupting chemicals as potential risk factor for estrogen-dependent cancers.
Rutkowska AZ; Szybiak A; Serkies K; Rachoń D
Pol Arch Med Wewn; 2016 Aug; 126(7-8):562-70. PubMed ID: 27509913
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptors and the tumor microenvironment: A new paradigm in breast cancer biology.
Burks H; Pashos N; Martin E; Mclachlan J; Bunnell B; Burow M
Mol Cell Endocrinol; 2017 Dec; 457():13-19. PubMed ID: 28012841
[TBL] [Abstract][Full Text] [Related]
6. Endocrine disrupting chemicals and bone.
Turan S
Best Pract Res Clin Endocrinol Metab; 2021 Sep; 35(5):101495. PubMed ID: 33618984
[TBL] [Abstract][Full Text] [Related]
7. Estrogens and endocrine-disrupting chemicals differentially impact the bioenergetic fluxes of mammary epithelial cells in two- and three-dimensional models.
Lacouture A; Breton Y; Weidmann C; Goulet SM; Germain L; Pelletier M; Audet-Walsh É
Environ Int; 2023 Sep; 179():108132. PubMed ID: 37657410
[TBL] [Abstract][Full Text] [Related]
8. Endocrine-Disrupting Chemicals and Breast Cancer: Disparities in Exposure and Importance of Research Inclusivity.
Santaliz Casiano A; Lee A; Teteh D; Madak Erdogan Z; Treviño L
Endocrinology; 2022 May; 163(5):. PubMed ID: 35325096
[TBL] [Abstract][Full Text] [Related]
9. Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process.
Lee HM; Hwang KA; Choi KC
Mol Cell Endocrinol; 2017 Dec; 457():103-113. PubMed ID: 28042023
[TBL] [Abstract][Full Text] [Related]
10. Integrated Bioinformatics, Environmental Epidemiologic and Genomic Approaches to Identify Environmental and Molecular Links between Endometriosis and Breast Cancer.
Roy D; Morgan M; Yoo C; Deoraj A; Roy S; Yadav VK; Garoub M; Assaggaf H; Doke M
Int J Mol Sci; 2015 Oct; 16(10):25285-322. PubMed ID: 26512648
[TBL] [Abstract][Full Text] [Related]
11. Endocrine disrupting chemicals and breast cancer: a systematic review of epidemiological studies.
Wan MLY; Co VA; El-Nezami H
Crit Rev Food Sci Nutr; 2022; 62(24):6549-6576. PubMed ID: 33819127
[TBL] [Abstract][Full Text] [Related]
12. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
Giulivo M; Lopez de Alda M; Capri E; Barceló D
Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
[TBL] [Abstract][Full Text] [Related]
13. Estrogen Receptor β as a Possible Double-Edged Sword Molecule in Breast Cancer: A Mechanism of Alteration of Its Role by Exposure to Endocrine-Disrupting Chemicals.
Hirao-Suzuki M
Biol Pharm Bull; 2021; 44(11):1594-1597. PubMed ID: 34719637
[TBL] [Abstract][Full Text] [Related]
14. Endocrine-Disrupting Chemicals and Disease Endpoints.
Ahn C; Jeung EB
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
[TBL] [Abstract][Full Text] [Related]
15. Estrogenic compounds as exogenous modulators of physiological functions in molluscs: Signaling pathways and biological responses.
Balbi T; Ciacci C; Canesi L
Comp Biochem Physiol C Toxicol Pharmacol; 2019 Aug; 222():135-144. PubMed ID: 31055067
[TBL] [Abstract][Full Text] [Related]
16. Hypothesis: Activation of rapid signaling by environmental estrogens and epigenetic reprogramming in breast cancer.
Treviño LS; Wang Q; Walker CL
Reprod Toxicol; 2015 Jul; 54():136-40. PubMed ID: 25554384
[TBL] [Abstract][Full Text] [Related]
17. Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk.
Hu WY; Shi GB; Hu DP; Nelles JL; Prins GS
Mol Cell Endocrinol; 2012 May; 354(1-2):63-73. PubMed ID: 21914459
[TBL] [Abstract][Full Text] [Related]
18. Combined Effects of Different Endocrine-Disrupting Chemicals (EDCs) on Prostate Gland.
De Falco M; Laforgia V
Int J Environ Res Public Health; 2021 Sep; 18(18):. PubMed ID: 34574693
[TBL] [Abstract][Full Text] [Related]
19. Endocrine-Disrupting Chemicals and Their Effects during Female Puberty: A Review of Current Evidence.
Lucaccioni L; Trevisani V; Marrozzini L; Bertoncelli N; Predieri B; Lugli L; Berardi A; Iughetti L
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197344
[TBL] [Abstract][Full Text] [Related]
20. Impact of endocrine disrupting chemicals on onset and development of female reproductive disorders and hormone-related cancer.
Scsukova S; Rollerova E; Bujnakova Mlynarcikova A
Reprod Biol; 2016 Dec; 16(4):243-254. PubMed ID: 27692877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
